No known drug interactions for the matched ingredients — not a guarantee none exist. Check your meds →
Dietary supplement

P.E.A. Endocannabinoid Support Ingredients & Drug Interactions

by AOR Advanced Orthomolecular Research Advanced

Capsule Category: Non-nutrient/non-botanical
No known interaction
The interaction bottom line No known interaction

P.E.A. Endocannabinoid Support is a dietary supplement by AOR Advanced Orthomolecular Research Advanced with 1 active ingredient. Its ingredients are commonly taken for chronic pain, nerve (neuropathic) pain, inflammation.We don’t currently list a known drug interaction for its mapped ingredients — but that doesn’t guarantee none exist, so always confirm with your pharmacist.

HelloPharmacist Scorecard of P.E.A. Endocannabinoid Support by AOR Advanced Orthomolecular Research Advanced

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Full disclosure
Ingredient Transparency · database check
Full

Every active ingredient lists its own amount on the label.

Why this rating?
  • The label discloses an exact amount for 1 of its 1 active ingredient.
  • No proprietary blends here — you can verify the dose of every single component.

This supplement contains one active ingredient: palmitoylethanolamide (PEA), a naturally occurring compound in your body thought to play a role in managing inflammation and discomfort. The capsule itself is the only other ingredient.

Does it work?

Moderate evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Moderate

Some clinical evidence supports this product's ingredients for its stated purpose, but it isn't conclusive.

Why this rating?
  • The label markets this product for: Endocannabinoid system support.
  • We looked for evidence on: Chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS), Complex regional pain syndrome, Diabetic neuropathy, Fibromyalgia, Inflammatory bowel disease (IBD), Interstitial cystitis — and 4 related terms.
  • The strongest evidence on file: Palmitoylethanolamide (pea) is rated "Possibly Effective" for Osteoarthritis (Natural Medicines).
  • Also on file: Palmitoylethanolamide (pea) is rated "Insufficient Reliable Evidence To Rate" for Migraine headache, Inflammatory bowel disease (IBD), Diabetic neuropathy, Fibromyalgia, and more.

PEA shows possibly effective evidence for osteoarthritis. For spinal cord injury, the evidence leans toward possibly ineffective.

For carpal tunnel syndrome, migraine headache, autism spectrum disorder, and cannabis use disorder, there isn't enough reliable evidence in our data to rate whether it works.

The evidence, ingredient by ingredient Palmitoylethanolamide (pea)

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 1 of the 1 matched ingredient.
  • Pregnancy & breastfeeding safety ratings cover 1 of 1.
  • General safety write-ups exist for 1 of 1.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

PEA is generally well tolerated in studies, though long-term safety data are limited. The most common side effect when taken by mouth is nausea, which appears rarely and is mild.

If you apply a topical form (a lotion), about 13% of people with dry skin reported stinging, scaling, reddening, or worsened itching — but these happened no more often than with a plain lotion base. Do not use PEA during pregnancy or breastfeeding.

The safety information is not sufficient to know either way, so the guidance is to avoid it until more data exist. Talk with your doctor or pharmacist if you're pregnant, nursing, or planning to become pregnant.

Side effects, ingredient by ingredient Palmitoylethanolamide (pea)

Meds to double-check

No known interactions
Known Interaction Concern · database check
No known interactions

No medication interactions are currently documented for the matched ingredients — that isn't a guarantee none exist.

Why this rating?
  • None of the 1 matched ingredient has a documented medication interaction on file.

No interactions are documented in our data for palmitoylethanolamide. Always check your exact medications with the search tool on this page before starting any new supplement.

The bottom line

Scorecard at a glanceFully disclosed formula with some supporting evidence for its stated purpose. No medication interactions are currently documented, and safety information is well characterized.

PEA may be worth considering if you have osteoarthritis and want to explore a natural option. If you're pregnant, breastfeeding, or take any regular medications, check with your pharmacist first — even though no interactions are documented, your personal situation matters.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 1 of 1 active ingredient matched to our full ingredient reviews (monographs). Based on the product label dated Mar 24, 2020.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about P.E.A. Endocannabinoid Support, straight from the product label.

Brand AOR Advanced Orthomolecular Research Advanced
Barcode (UPC) 624917084160
Net contents 90 Vegetarian Capsule(s)
Market status On market
Date entered into DSLD Mar 24, 2020
DSLD ID 214860
Product type Non-nutrient/non-botanical
Supplement form Capsule
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Vegan, Vegetarian, Adult (18 - 50 Years), Gluten Free, Dairy Free
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for P.E.A. Endocannabinoid Support by AOR Advanced Orthomolecular Research Advanced, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container
90
UPC/BARCODE
624917084160
IngredientAmount% DV
Palmitoylethanolamide1200 mg, 400 mg--

Other ingredients: Capsule

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Formulation

GMP Manufacturing Quality assured Independent testing

Discussion: Micronized Palmitoylethanolamide (PEA) has widespread activity in supporting and sustaining the endocannabinoid system.

Leading endocannabinoid nutrition

Vegan

Non-GMO Gluten free

AOR guarantees that all ingredients have been declared on the label.

Made without wheat, gluten, corn, nuts, peanuts, sesame seeds, sulfites, mustard, soy, dairy, eggs, fish, shellfish or any animal byproduct.

Precautions

Do not use if safety seal is broken

Caution: Consult a healthcare practitioner for use beyond 40 days or if symptoms persist or worsen.

Warning: Consult your physician before use if you’re pregnant, lactating, have a medical condition, or if you’re taking any medication.

Keep out of reach of children.

To report a serious adverse event or obtain product information, call 1-866-215-0450

Storage

Store tightly sealed in a cool, dry place

Suggested/Recommended/Usage/Directions

Directions: Take 1 capsule, 1-3 times daily, with or without food; or as directed by a qualified health care practitioner.

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

FDA Statement of Identity

Dietary Supplement

General Statements

Product of Canada

See for yourself

P.E.A. Endocannabinoid Support by AOR Advanced Orthomolecular Research Advanced label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in P.E.A. Endocannabinoid Support by AOR Advanced Orthomolecular Research Advanced

This is the 1 active ingredient this product is made of. Select it to open its full monograph.

Serving size1 Capsule(s) Dosage formCapsule Servings per container90 Amounts shown are per serving.

Palmitoylethanolamide

No known
interactions
1200 mg per serving

Palmitoylethanolamide (PEA) is a fat-like molecule made naturally in the body and studied mainly for pain and inflammation. Some research suggests it...

Palmitoylethanolamide monograph & interactions

Other (inactive) ingredients: Capsule. These complete the product’s ingredient list but are not active constituents.

Interaction report

P.E.A. Endocannabinoid Support by AOR Advanced Orthomolecular Research Advanced Drug Interactions

We don’t currently list any known drug interactions for the mapped ingredients in P.E.A. Endocannabinoid Support. This doesn’t guarantee none exist — always confirm with your pharmacist before combining a supplement with your medications.

The maker

Brand information

Manufacturer and brand details for P.E.A. Endocannabinoid Support, from the product label.

AOR Advanced Orthomolecular Research Advanced

See all AOR Advanced Orthomolecular Research Advanced products
Name
AOR Inc.
Street Address
30 Industrial West
City
Clifton
State
NJ
ZipCode
07012
Phone Number
1-866-215-0450
Pharmacist Counseling Corner

P.E.A. Endocannabinoid Support by AOR Advanced Orthomolecular Research Advanced: Common Questions

Does P.E.A. Endocannabinoid Support by AOR Advanced Orthomolecular Research Advanced interact with any medications?
We do not currently list a known interaction for the mapped ingredients in P.E.A. Endocannabinoid Support. This does not guarantee none exist, so confirm with your pharmacist.
How can one product interact with so many drugs?
P.E.A. Endocannabinoid Support contains a single active ingredient, and that one ingredient can interact with many different medications on its own. We check it against each medication and show the mechanism responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
What is palmitoylethanolamide, and what does it do?
Palmitoylethanolamide (PEA) is a compound your body makes naturally. It's thought to help manage inflammation and discomfort, particularly in conditions like osteoarthritis.
Does PEA work for migraine headaches?
There isn't enough reliable evidence in our data to say whether PEA helps migraines. If you're considering it for that reason, ask your pharmacist whether the research might support a trial.
Can I take this if I'm pregnant or breastfeeding?
No. There isn't enough safety information to know whether PEA is safe during pregnancy or while breastfeeding, so the guidance is to avoid it. Talk with your doctor or pharmacist if you're in either situation.
What are the side effects?
PEA is generally well tolerated. Nausea is the most commonly reported side effect when taken by mouth, but it's rare and mild. Long-term safety data are limited, so watch for any unexpected changes and report them to your pharmacist.
Is this the same as CBD or cannabis?
No. PEA is a separate compound your body naturally produces. It's sometimes called an 'endocannabinoid-like' substance because it acts on similar pathways, but it's distinct from cannabis compounds.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if P.E.A. Endocannabinoid Support is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

P.E.A. Endocannabinoid Support label
Go deeper

The Full Monographs Behind P.E.A. Endocannabinoid Support’s Ingredients

Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.

Sources

Sources & How We Checked

P.E.A. Endocannabinoid Support's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 4 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Palmitoylethanolamide (pea) 4 references
  1. Indraccolo U, Barbieri F. Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations. Eur J Obstet Gynecol Reprod Biol. 2010 May;150(1):76-9. PubMed
  2. Murina F, Graziottin A, Felice R, Radici G, Tognocchi C. Vestibulodynia: synergy between palmitoylethanolamide + transpolydatin and transcutaneous electrical nerve stimulation. J Low Genit Tract Dis. 2013 Apr;17(2):111-6.
  3. Papetti L, Sforza G, Tullo G, et al. Tolerability of palmitoylethanolamide in a pediatric population suffering from migraine: A pilot study. Pain Res Manag 2020;2020:3938640. PubMed
  4. Visse K, Blome C, Phan NQ, Augustin M, Ständer S. Efficacy of body lotion containing N-palmitoylethanolamine in subjects with chronic pruritus due to dry skin: A dermatocosmetic study. Acta Derm Venereol. 2017;97(5):639-641. PubMed

See these in context on the Palmitoylethanolamide (pea) monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring